Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Bezin

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Headache|January 27, 2023
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, TuscanyGiulia Hyeraci, Rosa Gini, Julien Bezin, et al.
Cardiovascular Diabetology|March 14, 2021
Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and designKamel Mohammedi, Nathalie Préaubert, Tanguy Cariou, et al.
Acta Psychiatrica Scandinavica|June 20, 2023
Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover studyMarie Tournier, Anne Bénard-Laribière, Fabrice Jollant, et al.
British Journal of Haematology|July 24, 2023
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control studyMarion Allouchery, Cécile Tomowiak, Allison Singier, et al.
Vascular Medicine (London, England)|November 7, 2023
Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort studyLoubna Dari, Joël Constans, Carine Boulon, et al.
Pharmacoepidemiology and Drug Safety|January 27, 2017
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndromeJulien Bezin, Rolf H H Groenwold, M Sanni Ali, et al.
Frontiers in Cardiovascular Medicine|September 29, 2025
Correction: Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ studyEmeline Laurent, Lucile Godillon, Marc-Florent Tassi, et al.
Frontiers in Cardiovascular Medicine|June 27, 2025
Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ studyEmeline Laurent, Lucile Godillon, Marc-Florent Tassi, et al.
Therapie|March 13, 2019
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in FranceAnne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2022
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancerPietro Rosellini, Samuel Amintas, Charline Caumont, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Headache|January 27, 2023
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, TuscanyGiulia Hyeraci, Rosa Gini, Julien Bezin, et al.
Cardiovascular Diabetology|March 14, 2021
Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and designKamel Mohammedi, Nathalie Préaubert, Tanguy Cariou, et al.
Acta Psychiatrica Scandinavica|June 20, 2023
Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover studyMarie Tournier, Anne Bénard-Laribière, Fabrice Jollant, et al.
British Journal of Haematology|July 24, 2023
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control studyMarion Allouchery, Cécile Tomowiak, Allison Singier, et al.
Vascular Medicine (London, England)|November 7, 2023
Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort studyLoubna Dari, Joël Constans, Carine Boulon, et al.
Pharmacoepidemiology and Drug Safety|January 27, 2017
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndromeJulien Bezin, Rolf H H Groenwold, M Sanni Ali, et al.
Frontiers in Cardiovascular Medicine|September 29, 2025
Correction: Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ studyEmeline Laurent, Lucile Godillon, Marc-Florent Tassi, et al.
Frontiers in Cardiovascular Medicine|June 27, 2025
Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ studyEmeline Laurent, Lucile Godillon, Marc-Florent Tassi, et al.
Therapie|March 13, 2019
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in FranceAnne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2022
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancerPietro Rosellini, Samuel Amintas, Charline Caumont, et al.
Pageof 8